FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women Read more
Good Therapeutics Announces Acquisition of Conditionally Active PD-1-regulated IL-2 Program by Roche Read more
Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients Read more
AceLink Therapeutics Receives Orphan Drug Designation for its Novel GCS Inhibitor AL01211 for the Treatment of Fabry Disease Read more
ixlayer Partners with Curavit to Enable Convenient Patient Medical Testing Services for Decentralized Clinical Trials Read more
NaNotics to Collaborate with Mass General Cancer Center (MGCC) on Novel Nanomedicine for Treating Cancer Read more
Kite’s CAR T-cell Therapy Tecartus Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (r/r ALL) Read more